[
  {
    "ts": null,
    "headline": "Vertex Pharmaceuticals (VRTX) Advances But Underperforms Market: Key Facts",
    "summary": "Vertex Pharmaceuticals (VRTX) closed at $492.47 in the latest trading session, marking a +0.01% move from the prior day.",
    "url": "https://finnhub.io/api/news?id=cacabb4e93750633441fcc6c1d2b5af152500b937b8ab9f8eb11891ac881928f",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745531414,
      "headline": "Vertex Pharmaceuticals (VRTX) Advances But Underperforms Market: Key Facts",
      "id": 134067726,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "VRTX",
      "source": "Yahoo",
      "summary": "Vertex Pharmaceuticals (VRTX) closed at $492.47 in the latest trading session, marking a +0.01% move from the prior day.",
      "url": "https://finnhub.io/api/news?id=cacabb4e93750633441fcc6c1d2b5af152500b937b8ab9f8eb11891ac881928f"
    }
  },
  {
    "ts": null,
    "headline": "Top 20 biopharmas’ market cap rises 6% in Q1 2025 amid tariff headwinds",
    "summary": "The biopharmaceutical industry is positioned for continued recovery, driven by recent FDA approvals and billion-dollar strategic collaborations.",
    "url": "https://finnhub.io/api/news?id=088c452f219185e403a20d2443ff40174e6694985d184b27750635adbbb1e9fa",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745516964,
      "headline": "Top 20 biopharmas’ market cap rises 6% in Q1 2025 amid tariff headwinds",
      "id": 134067727,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "VRTX",
      "source": "Yahoo",
      "summary": "The biopharmaceutical industry is positioned for continued recovery, driven by recent FDA approvals and billion-dollar strategic collaborations.",
      "url": "https://finnhub.io/api/news?id=088c452f219185e403a20d2443ff40174e6694985d184b27750635adbbb1e9fa"
    }
  }
]